Literature DB >> 843523

Equilibration of fucosyl glycoprotein pools in HeLa cells.

P D Yurchenco, P H Atkinson.   

Abstract

The pool sizes, label equilibration times, and specific radioactivity relationships of fucosyl glycoproteins and precursors have been examined in exponentially growing HeLa S3 cells (generation time about 23 h) using a quantitative radioisotopic approach. The specific radioactivity of the precursor GDP-fucose (pool size 0.52 +/- 4% nmol/10(7) cells) equilibrates with radioactive fucose in the medium in about 1 h. 10(7) cells contain 5.3 +/- 16% nmol of glycoprotein fucose of which 96-98% resides in or on the cell surfaces and is equilibrated isotopically within 22 h of labeling; 2% or less is in an internal pool, some of which is precursor to plasma membranes and some of which is released as soluble glycoprotein directly to the medium without random mixing with the plasma membrane glycoprotein. Because we cannot rule out the presence of internal free fucose, 2% of the total glycoprotein fucose could be in the degradative pathway being recycled internally before release of free fucose. In rate terms and in a particular culture where 10(7) cells contained 4.4 nmol of glycoprotein fucose, a total of 11.1 nmol of glycoprotein fucose is synthesized per generation (9-11% of the total cell glycoprotein fucose/h). Of this, 2.5 nmol of glycoprotein fucose per generation is released directly into the growth medium without mixing with the plasma membrane glycoprotein fucose. The small internal pool feeding glycoprotein fucose to the plasma membrane does so at the rate of 8.6 nmol/10(7) cells per generation, 4.2 nmol per generation of which, after mixing with the plasma membrane glycoprotein fucose, is ultimately released into the growth medium, 75-80% as free frucose. This release process is independent of cell density and the presence of serum in the growth medium.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843523     DOI: 10.1021/bi00624a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Pathogenic Variants in Fucokinase Cause a Congenital Disorder of Glycosylation.

Authors:  Bobby G Ng; Jill A Rosenfeld; Lisa Emrick; Mahim Jain; Lindsay C Burrage; Brendan Lee; William J Craigen; David R Bearden; Brett H Graham; Hudson H Freeze
Journal:  Am J Hum Genet       Date:  2018-11-29       Impact factor: 11.025

2.  Crystallization and preliminary X-ray characterization of the Vitis vinifera fucokinase:GDP-fucose pyrophosphorylase.

Authors:  Stephen Quirk
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-08-31

3.  Slc35c2 promotes Notch1 fucosylation and is required for optimal Notch signaling in mammalian cells.

Authors:  Linchao Lu; Xinghua Hou; Shaolin Shi; Christian Körner; Pamela Stanley
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

4.  Therapeutic Monosaccharides: Looking Back, Moving Forward.

Authors:  Paulina Sosicka; Bobby G Ng; Hudson H Freeze
Journal:  Biochemistry       Date:  2019-08-22       Impact factor: 3.162

5.  Purification, crystallization and preliminary X-ray characterization of the human GTP fucose pyrophosphorylase.

Authors:  Stephen Quirk; Katherine L Seley-Radtke
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-03-25

6.  Synthesis of membrane glycoproteins in rat small-intestinal villus cells. Redistribution of L-[1,5,6-3H]fucose-labelled membrane glycoproteins among Golgi, lateral basal and microvillus membranes in vivo.

Authors:  A Quaroni; K Kirsch; M M Weiser
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

7.  Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium.

Authors:  A Karsan; C J Cornejo; R K Winn; B R Schwartz; W Way; N Lannir; R Gershoni-Baruch; A Etzioni; H D Ochs; J M Harlan
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

Review 8.  Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review.

Authors:  Luca Maroni; Stan F J van de Graaf; Simon D Hohenester; Ronald P J Oude Elferink; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

9.  Surface-membrane biogenesis in rat intestinal epithelial cells at different stages of maturation.

Authors:  A Quaroni; K Kirsch; A Herscovics; K J Isselbacher
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

10.  Metabolic labeling of fucosylated glycans in developing zebrafish.

Authors:  Karen W Dehnert; Brendan J Beahm; Thinh T Huynh; Jeremy M Baskin; Scott T Laughlin; Wei Wang; Peng Wu; Sharon L Amacher; Carolyn R Bertozzi
Journal:  ACS Chem Biol       Date:  2011-04-05       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.